Financial results - MYRIAM PHARMA SRL

Financial Summary - Myriam Pharma Srl
Unique identification code: 17648466
Registration number: J12/2036/2005
Nace: 4773
Sales - Ron
3.090.316
Net Profit - Ron
98.474
Employees
16
Open Account
Company Myriam Pharma Srl with Fiscal Code 17648466 recorded a turnover of 2024 of 3.090.316, with a net profit of 98.474 and having an average number of employees of 16. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Myriam Pharma Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 1.798.279 1.928.937 2.161.923 2.076.231 2.203.500 2.632.378 2.501.238 2.424.800 2.758.231 3.090.316
Total Income - EUR 1.804.699 1.934.817 2.162.634 2.078.623 2.206.281 2.633.645 2.502.561 2.431.167 2.770.768 3.123.820
Total Expenses - EUR 1.739.840 1.879.271 2.139.967 2.025.105 2.105.185 2.510.951 2.393.599 2.372.272 2.706.684 3.008.718
Gross Profit/Loss - EUR 64.860 55.546 22.667 53.518 101.096 122.694 108.963 58.896 64.084 115.102
Net Profit/Loss - EUR 56.163 47.706 15.062 43.428 84.913 105.300 94.252 50.522 54.902 98.474
Employees 19 22 27 28 25 23 23 24 24 16
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 12.7%, from 2.758.231 euro in the year 2023, to 3.090.316 euro in 2024. The Net Profit increased by 43.879 euro, from 54.902 euro in 2023, to 98.474 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Myriam Pharma Srl

Rating financiar

Financial Rating -
MYRIAM PHARMA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Myriam Pharma Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Myriam Pharma Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Myriam Pharma Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Myriam Pharma Srl - CUI 17648466

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 97.214 69.056 58.138 56.361 54.710 53.953 51.182 50.653 60.816 64.030
Current Assets 885.508 932.771 962.939 835.856 972.246 1.016.163 1.063.113 963.000 867.106 971.888
Inventories 339.753 425.335 420.442 305.987 374.788 370.131 318.477 322.808 347.737 496.734
Receivables 171.492 108.560 213.143 239.661 255.495 280.182 279.713 300.009 331.589 271.979
Cash 374.263 398.876 329.354 290.209 341.963 365.850 464.923 340.184 187.780 203.176
Shareholders Funds 488.734 524.424 530.611 541.608 593.850 635.664 694.541 64.176 118.874 98.522
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 493.987 480.062 490.466 350.609 433.106 434.452 419.754 949.477 809.047 937.481
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 971.888 euro in 2024 which includes Inventories of 496.734 euro, Receivables of 271.979 euro and cash availability of 203.176 euro.
The company's Equity was valued at 98.522 euro, while total Liabilities amounted to 937.481 euro. Equity decreased by -19.688 euro, from 118.874 euro in 2023, to 98.522 in 2024.

Risk Reports Prices

Reviews - Myriam Pharma Srl

Comments - Myriam Pharma Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.